Business and Finance

Acquisition is 3PL provider's largest one yet

Acquisition grows Antares’ track-and-trace presence

Strengthens the CRO's scientific capabilities in cell and gene therapy space

Lab development project features 9,000-square-foot expansion

Combine their expertise in immunology and infectious diseases to speed up development of mAbs for influenza

Acquires Scientific Commercialization, a medical affairs consulting and analytics business

PBM's own specialty pharmacy unit adds CareMetx Health, growing its coverage base to the eastern US

Deal will help expand its pharma presence

Becomes a partner in UK consortium focused on enabling new and disruptive manufacturing technologies

UK cell and gene therapy location expected to be cGMP-ready by mid-2022

Will help biomed startups in furthering oncology R&D

There are currently 100,000 doses standing by

$180M collaboration aims to introduce multiple vaccine candidates in 2022

Two-dose COVAXIN currently under EUA in India

CDMO to take over operations, including equipment and workforce, at site in Couvet, Switzerland

Deal completes Verista's lifecycle support for pharma, which now includes consulting, technology and manufacturing

Agreement provides Acentrus with specialty pharmacy accreditation

In Phase III at the moment, mRNA dose will be produced at Bayer's Wuppertal, Germany facility

Production expected to begin in the second quarter

Forms three new business units to integrate healthcare services

Komodo-BHI agreement grows patient database to 325M

Technology partnership focused on improving patient-level data integration

Terms provide equitable access to Covid-19 vaccine

Cold-chain deal strives to contribute to vaccine distribution efforts

Powered by AI analytics, healthcare partnership aims to increase member engagement

Latest air cargo collaboration provides pandemic response support

Acquisition of point-of-care diagnostics provider could reach upwards of $550M

Alliance strives to develop novel AAV vectors

Secures $76M in funding for Boston-area manufacturing and innovation center

Goal is to merge companies’ digital therapeutics and technology expertise